Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/1/23 → 07/24/25 |
Funding
- Boehringer Ingelheim Pharmaceutical: $17,504.50
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 over at Least 52 weeks in Patients with Idiopathic Pulmonary Fibrosis (IPF)
- Desai, Alpa (PI)
- Patel, Jignesh (CoPI)
Project: Research